INO
Inovio Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
3.51 / 10
Netural
Inovio's fundamental analysis scores 3.5/10, placing it in a neutral category. Key concerns include low current and fixed assets turnover ratios (both near zero), signaling inefficiency in asset utilization. Revenue-MV and Profit-MV are moderate, while Cash-MV is slightly negative. Gross profit margin is a strong 100%, but the Net profit / Total profit ratio of 100% may reflect accounting specifics rather than profitability robustness. PB-ROE is 0.2689, in group 2 with a quality score of 1/3. Overall, the firm exhibits defensive characteristics with limited growth potential.
Analysis Checks(5/10)
Revenue-MV
Value-0.26
Score2/3
Weight21.11%
1M Return11.69%
Value-0.26
Score2/3
Weight21.11%
1M Return11.69%
Gross profit margin (%)
Value100.00
Score3/3
Weight18.59%
1M Return10.80%
Value100.00
Score3/3
Weight18.59%
1M Return10.80%
PB-ROE
Value0.27
Score1/3
Weight12.79%
1M Return7.02%
Value0.27
Score1/3
Weight12.79%
1M Return7.02%
Fixed assets turnover ratio
Value0.01
Score1/3
Weight-2.20%
1M Return-1.64%
Value0.01
Score1/3
Weight-2.20%
1M Return-1.64%
Cash-MV
Value-0.07
Score2/3
Weight13.87%
1M Return7.73%
Value-0.07
Score2/3
Weight13.87%
1M Return7.73%
Inventory turnover ratio
Value47.85
Score3/3
Weight8.13%
1M Return5.26%
Value47.85
Score3/3
Weight8.13%
1M Return5.26%
Profit-MV
Value0.46
Score2/3
Weight13.85%
1M Return7.79%
Value0.46
Score2/3
Weight13.85%
1M Return7.79%
Current assets turnover ratio
Value0.00
Score0/3
Weight-2.53%
1M Return-1.88%
Value0.00
Score0/3
Weight-2.53%
1M Return-1.88%
Asset-MV
Value-0.50
Score1/3
Weight16.79%
1M Return8.74%
Value-0.50
Score1/3
Weight16.79%
1M Return8.74%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight-0.41%
1M Return-0.30%
Value100.00
Score0/3
Weight-0.41%
1M Return-0.30%
Revenue-MV
Value-0.26
Score2/3
Weight21.11%
1M Return11.69%
Value-0.26
Score2/3
Weight21.11%
1M Return11.69%
Inventory turnover ratio
Value47.85
Score3/3
Weight8.13%
1M Return5.26%
Value47.85
Score3/3
Weight8.13%
1M Return5.26%
Gross profit margin (%)
Value100.00
Score3/3
Weight18.59%
1M Return10.80%
Value100.00
Score3/3
Weight18.59%
1M Return10.80%
Profit-MV
Value0.46
Score2/3
Weight13.85%
1M Return7.79%
Value0.46
Score2/3
Weight13.85%
1M Return7.79%
PB-ROE
Value0.27
Score1/3
Weight12.79%
1M Return7.02%
Value0.27
Score1/3
Weight12.79%
1M Return7.02%
Current assets turnover ratio
Value0.00
Score0/3
Weight-2.53%
1M Return-1.88%
Value0.00
Score0/3
Weight-2.53%
1M Return-1.88%
Fixed assets turnover ratio
Value0.01
Score1/3
Weight-2.20%
1M Return-1.64%
Value0.01
Score1/3
Weight-2.20%
1M Return-1.64%
Asset-MV
Value-0.50
Score1/3
Weight16.79%
1M Return8.74%
Value-0.50
Score1/3
Weight16.79%
1M Return8.74%
Cash-MV
Value-0.07
Score2/3
Weight13.87%
1M Return7.73%
Value-0.07
Score2/3
Weight13.87%
1M Return7.73%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight-0.41%
1M Return-0.30%
Value100.00
Score0/3
Weight-0.41%
1M Return-0.30%
Is INO undervalued or overvalued?
- INO scores 3.51/10 on fundamentals and holds a Fair valuation at present. Backed by its -291.89% ROE, -59281.69% net margin, -1.06 P/E ratio, -14.77 P/B ratio, and 38.60% earnings growth, these metrics solidify its Netural investment rating.
